Tg Therapeutics (TGTX) Cash from Operations (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Cash from Operations of 17894000.0 for Q1 2026, up 37.68% year-over-year from 12996413.65 in Q1 2025, and down 191.02% quarter-over-quarter from 19660000.0 in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Cash from Operations (2011 - 2026) Analysis & Trends
Tg Therapeutics' Cash from Operations history runs 16 years deep, the most recent figure standing at 17894000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 37.68% year-over-year to 17894000.0; the TTM figure through Mar 2026 stood at 13951000.0 (up 77.14% YoY), while the FY2025 annual figure was 24772000.0, up 38.86% from the prior year.
- Cash from Operations for Q1 2026 stood at 17894000.0, down from 19660000.0 in the prior quarter.
- The five-year high for Cash from Operations was 83704000.0 in Q3 2023, with the low at 68689000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 23153000.0 (2025), against an average of 17103882.35.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations surged 342.66% in 2023, then tumbled 249.88% in 2025.
- Tg Therapeutics' Cash from Operations stood at 23870000.0 in 2022, then jumped by 44.66% to 13210000.0 in 2023, then sank by 94.1% to 25641000.0 in 2024, then soared by 176.67% to 19660000.0 in 2025, then sank by 191.02% to 17894000.0 in 2026.
- Business Quant data shows TGTX's Cash from Operations at 17894000.0 in Q1 2026, 19660000.0 in Q4 2025, and 23153000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 39.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.26 Mn |
| Mar 31, 2026 | -17.89 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Sep 30, 2025 | -23.15 Mn |
| Jun 30, 2025 | 7.44 Mn |
| Mar 31, 2025 | -28.72 Mn |
| Dec 31, 2024 | -25.64 Mn |
| Sep 30, 2024 | -12.21 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | -8.21 Mn |
| Dec 31, 2023 | -13.21 Mn |
| Sep 30, 2023 | 83.70 Mn |
| Jun 30, 2023 | -42.01 Mn |
| Mar 31, 2023 | -59.90 Mn |
| Dec 31, 2022 | -23.87 Mn |
| Sep 30, 2022 | -34.50 Mn |
| Jun 30, 2022 | -49.12 Mn |
| Mar 31, 2022 | -68.69 Mn |
| Dec 31, 2021 | -86.91 Mn |
| Sep 30, 2021 | -67.20 Mn |